Bausch & Lomb Corp

Ophthalmic Goods·VAUGHAN, A6·FY end 12/31·CIK 1860742

CEO Pay Ratio

632:1

CEO Total Comp

—

Median Employee

$50,904

Revenue

$5.1B

FY 2025

Net Income

-$360.0M

FY 2025

Free Cash Flow

-$66.0M

FY 2025

Net Margin

-7.1%

Insider Net (180d)

$807.2K

6 buys / 0 sales

CEO Pay Accountability

CEO comp as % of net income

—

Not enough data to compute.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

4-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	Trend
Revenue	$5.1B	$4.8B	$4.1B	$3.8B
Gross Profit	—	—	—	—	—
Operating Income	$113.0M	$162.0M	$130.0M	$207.0M
Net Income	-$360.0M	-$317.0M	-$260.0M	$6.0M
Operating CF	$283.0M	$232.0M	-$17.0M	$345.0M
Capex	$349.0M	$291.0M	$181.0M	$175.0M
Free Cash Flow	-$66.0M	-$59.0M	-$198.0M	$170.0M
Buybacks	—	—	—	—	—
Dividends	—	—	—	—	—

Gross Margin	—	—	—	—	—
Operating Margin	2.2%	3.4%	3.1%	5.5%
Net Margin	-7.1%	-6.6%	-6.3%	0.2%
FCF Margin	-1.3%	-1.2%	-4.8%	4.5%
R&D / Revenue	—	—	—	—	—
Effective Tax	-11.0%	-30.3%	-49.4%	79.5%
Debt / Equity	1.56	1.47	1.33	0.34
Buybacks / FCF	—	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Sam A. EldessoukyExecutive Vice President and Chief Financial Officer	$778.0K	$2.5M	$660.0K	$994.0K	$15.8K	$5.0M
A. Robert D. BaileyExecutive Vice President and Chief Legal Officer	$767.9K	$1.7M	$450.0K	$673.2K	$27.3K	$3.6M
Yehia HashadM.D. Executive Vice President of Research & Development and Chief Medical Officer	$726.1K	$1.1M	$280.0K	$700.8K	$15.8K	$2.8M
Andrew J. StewartPresident, Global Pharmaceuticals and International Consumer	$629.1K	$990.6K	$260.0K	$604.8K	$15.8K	$2.5M